Figure 2:

Recommendations for the management of patients with asthma uncontrolled on fixed-dose combination ICS/LABA therapy, taken from the Canadian Thoracic Society 2012 guideline on the diagnosis and management of asthma (p. 144 and 158).³³ Beige boxes: original recommendations with identified problems and corresponding constructs. Blue box: proposed revision. *The proposed revision is for explanatory purposes only and should not be interpreted as an actual guideline recommendation. ICS = inhaled corticosteroid, LABA = long-acting β²-agonist, LTRA = leukotriene receptor agonist.